| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/17/2011 | US20110039927 Compositions comprising and processes for producing inorganic salts of hop acids |
| 02/17/2011 | US20110039926 Use of enantiomer (1s, 2r) milnacipran hydrochloride for the preventive treatment of suicidal behaviour in depressed patients |
| 02/17/2011 | US20110039925 Cyclobutyl sulfones as notch sparing gamma secretase inhibitors |
| 02/17/2011 | US20110039924 Alpha-amino acid derivatives for improving solubility |
| 02/17/2011 | US20110039923 Novel standardized composition, method of manufacture and use in the resolution of rna virus infection |
| 02/17/2011 | US20110039922 18beta-GLYCYRRHETINIC ACID DERIVATIVES AND SYNTHETIC METHOD THEREOF |
| 02/17/2011 | US20110039921 Cephalomannine derivatives, their preparation, pharmaceutical composition and use thereof |
| 02/17/2011 | US20110039920 Inhibitors of ikk-beta serine-theronine protein kinase |
| 02/17/2011 | US20110039919 Pharmaceutical compositions for inhibiting angiogenesis |
| 02/17/2011 | US20110039918 Single Nucleotide Polymorphisms (SNPs) in Genes Associated with Inflammatory Diseases |
| 02/17/2011 | US20110039917 High Concentration Chitosan-Nucleic Acid Polyplex Compositions |
| 02/17/2011 | US20110039916 Helper Virus-Free Herpesvirus Amplicon Particles and Uses Thereof |
| 02/17/2011 | US20110039915 IMMUNOSTIMULATORY siRNA MOLECULES |
| 02/17/2011 | US20110039914 Modified rnai polynucleotides and uses thereof |
| 02/17/2011 | US20110039913 Antisense modulation of hydroxysteroid 11-beta dehydrogenase 1 expression |
| 02/17/2011 | US20110039912 Therapeutic Agent for Neuroblastoma Targeting ARID3b |
| 02/17/2011 | US20110039911 METHOD OF INHIBITING NONSENSE-MEDIATED mRNA DECAY |
| 02/17/2011 | US20110039910 Modulation of apolipoprotein (a) expression |
| 02/17/2011 | US20110039909 Methods and materials for reducing gli2 expression |
| 02/17/2011 | US20110039908 Inhibiting Amyloid-Beta Peptide/Rage Interaction At The Blood-Brain Barrier |
| 02/17/2011 | US20110039906 Antibacterial combination therapy |
| 02/17/2011 | US20110039905 Benzimidazole derivatives as calcium channel blockers |
| 02/17/2011 | US20110039903 Acute Pharmacologic Augmentation of Psychotherapy with Enhancers of Learning or Conditioning |
| 02/17/2011 | US20110039902 PROCESS FOR PREPARING A CRYSTALLINE FORM COMPOUND OF 3-BENZYL-2-METHYL-2,3,3a,4,5,6,7,7a-OCTAHYDROBENZO[d]ISOXAZOL-4-ONE |
| 02/17/2011 | US20110039901 PROCESS FOR PREPARING A CRYSTALLINE FORM COMPOUND OF 3-BENZYL-2-METHYL-2,3,3a,4,5,6,7,7a-OCTAHYDROBENZO[d]ISOXAZOL-4-ONE |
| 02/17/2011 | US20110039900 Isothiozoles for treating conditions of the eye |
| 02/17/2011 | US20110039899 Gabapentin for the Treatment of Overactive Bladder, Stress Incontinence and BPH |
| 02/17/2011 | US20110039898 Method for scavenging free radicals and inhibiting tyrosinase and melanin |
| 02/17/2011 | US20110039897 Liquid formulation for deferiprone with palatable taste |
| 02/17/2011 | US20110039896 Novel 2-pyrrolidinyl-3-amido-6-amino-pyridine derivatives useful as potassium channel activators |
| 02/17/2011 | US20110039895 Prolyl hydroxylase inhibitors |
| 02/17/2011 | US20110039893 Gsk-3beta inhibitor |
| 02/17/2011 | US20110039892 Iminopyridine derivative and use thereof |
| 02/17/2011 | US20110039891 Methods for treating a disease in which Rho kinase is involved |
| 02/17/2011 | US20110039890 4-[2,3-Difluoro-6-(2-fluoro-4-methyl-phenylsulfanyl)-phenyl]-piperidine |
| 02/17/2011 | US20110039889 Compounds |
| 02/17/2011 | US20110039888 Asymmetric alpha functionalization and alpha, alpha bisfunctionalization of aldehydes and ketones |
| 02/17/2011 | US20110039887 Carbostyril derivatives including cilostazol for treating fatty liver |
| 02/17/2011 | US20110039886 Enhanced erythropoiesis and iron metabolism |
| 02/17/2011 | US20110039885 Methods for increasing endothelial progenitor cells |
| 02/17/2011 | US20110039884 Imidazopyridinones |
| 02/17/2011 | US20110039883 Azolopyridin-2-one derivatives as lipase and phospholipase inhibitors |
| 02/17/2011 | US20110039882 Phosphodiesterase 10a inhibitor |
| 02/17/2011 | US20110039881 Compositions and methods for treating middle-of-the-night insomnia |
| 02/17/2011 | US20110039880 Aryl substituted sulfonamide compounds and their use as anticancer agents |
| 02/17/2011 | US20110039879 Methods for increasing white blood cells |
| 02/17/2011 | US20110039878 Methods for reducing blood pressure |
| 02/17/2011 | US20110039877 Use of 3, 11b-cis-dihydrotetrabenazine in the treatment of multiple sclerosis and autoimmune myelitis |
| 02/17/2011 | US20110039876 Solution formulations of sirolimus and its analogs for cad treatment |
| 02/17/2011 | US20110039875 Pharamaceutical compositions for treating chronic pain and pain associated with neuropathy |
| 02/17/2011 | US20110039874 Monoacylglycerol lipase inhibitors for modulation of cannabinoid activity |
| 02/17/2011 | US20110039873 SUBSTITUTED PYRAZOLO[1,5-a] PYRIDINE COMPOUNDS HAVING MULTI-TARGET ACTIVITY |
| 02/17/2011 | US20110039872 Deuterium-enriched capecitabine |
| 02/17/2011 | US20110039871 Process for preparing bosentan |
| 02/17/2011 | US20110039870 Tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidines as antagonists of serotonin 5-ht6 receptors, methods for the production and use thereof |
| 02/17/2011 | US20110039869 Composition for inhibiting the activity of inositol 1,4,5-triphosphate receptor subtype iii |
| 02/17/2011 | US20110039868 Inhibitors of bruton's tyrosine kinase |
| 02/17/2011 | US20110039867 Pyrimidine derivatives which are antagonist of the vitronectin receptor |
| 02/17/2011 | US20110039866 Selective sphingosine-1-phosphate receptor antagonists |
| 02/17/2011 | US20110039864 Therapeutic compounds |
| 02/17/2011 | US20110039863 Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesis |
| 02/17/2011 | US20110039862 Protease Inhibitors |
| 02/17/2011 | US20110039861 Cyclic azaindole-3-carboxamides, their preparation and their use as pharmaceuticals |
| 02/17/2011 | US20110039860 Soluble epoxide hydrolase inhibitors, compositions containing such compounds and methods of treatment |
| 02/17/2011 | US20110039859 Susceptibility to bone damage |
| 02/17/2011 | US20110039858 Novel Compounds |
| 02/17/2011 | US20110039857 Piperidine and pyroolidine compounds |
| 02/17/2011 | US20110039856 Polymorphs of a c-met/hgfr inhibitor |
| 02/17/2011 | US20110039855 Tetrahydrocyclopenta[b]indole Androgen Receptor Modulators |
| 02/17/2011 | US20110039854 Linear and cyclic guanidine derivatives, method of preparation and uses thereof |
| 02/17/2011 | US20110039853 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
| 02/17/2011 | US20110039852 N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors |
| 02/17/2011 | US20110039851 Ccr10 antagonists |
| 02/17/2011 | US20110039850 Leukemia Treatment |
| 02/17/2011 | US20110039849 5-substituted-2-imino-thiazolidinone compounds and their use as inhibitors of bacterial infection |
| 02/17/2011 | US20110039848 Five-membered ring compound |
| 02/17/2011 | US20110039847 Amide derivatives as sirtuin modulators |
| 02/17/2011 | US20110039846 Iminopyridine derivatives and use thereof |
| 02/17/2011 | US20110039845 2-aminoquinazoline derivative |
| 02/17/2011 | US20110039844 6-7,dialkoxy quinazoline derivatives useful for treatment of cancer related disorders |
| 02/17/2011 | US20110039842 Compounds having antiviral properties |
| 02/17/2011 | US20110039841 Novel compounds, their preparation and use |
| 02/17/2011 | US20110039840 Spirocyclic derivatives as histone deacetylase inhibitors |
| 02/17/2011 | US20110039839 Cyanopyrroles |
| 02/17/2011 | US20110039838 Pyrrolotriazine compounds as kinase inhibitors |
| 02/17/2011 | US20110039837 Oxadiazoanthracene compounds for the treatment of diabetes |
| 02/17/2011 | US20110039836 Tricyclic antibiotics |
| 02/17/2011 | US20110039835 Substituted arylamide diazepinopyrimidone derivatives |
| 02/17/2011 | US20110039834 Novel pharmaceutical compositions for optimizing substitution treatments and extending the pharmacopoeia to global treatment of addictions |
| 02/17/2011 | US20110039833 1-benzoyl substituted diazepine derivatives as selective histamine h3 receptor agonists |
| 02/17/2011 | US20110039832 Dihydro)pyrrolo[2,1-a]isoquinolines |
| 02/17/2011 | US20110039831 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives |
| 02/17/2011 | US20110039830 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals |
| 02/17/2011 | US20110039829 Pyrazole-carboxamide derivatives as p2y12 antagonists |
| 02/17/2011 | US20110039828 Tetrahydroquinoline derivatives and a process for preparing the same |
| 02/17/2011 | US20110039827 Substituted hydroxamic acids and uses thereof |
| 02/17/2011 | US20110039826 Pharmaceutical compositions for the treatment of cancer and other diseases or disorders |
| 02/17/2011 | US20110039825 Ligands of alpha-adrenoceptors, dopamine, histamine, imidazoline and serotonin receptors and their use |
| 02/17/2011 | US20110039824 1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylate nuclear receptor inhibitors |
| 02/17/2011 | US20110039823 Oxazolidinone antibiotics |